Los Angeles Capital Management’s Harmony Biosciences HRMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$4.66M Buy
166,198
+99,647
+150% +$3.27M 0.02% 346
2025
Q4
$1.92M Sell
66,551
-808
-1% -$26.6K 0.01% 454
2025
Q3
$1.86M Buy
67,359
+25,933
+63% +$893K 0.01% 526
2025
Q2
$1.31M Buy
41,426
+1,524
+4% +$49K ﹤0.01% 573
2025
Q1
$1.32M Buy
39,902
+14,552
+57% +$522K 0.01% 488
2024
Q4
$872K Hold
25,350
﹤0.01% 662
2024
Q3
$1.01M Buy
25,350
+126
+0.5% +$4.43K ﹤0.01% 650
2024
Q2
$761K Hold
25,224
﹤0.01% 741
2024
Q1
$847K Buy
25,224
+1,076
+4% +$34.5K ﹤0.01% 741
2023
Q4
$780K Buy
24,148
+16,555
+218% +$462K ﹤0.01% 752
2023
Q3
$249K Sell
7,593
-14,093
-65% -$489K ﹤0.01% 1012
2023
Q2
$763K Buy
+21,686
New +$749K ﹤0.01% 725
2023
Q1
Sell
-5,312
Closed -$293K 1225
2022
Q4
$293K Buy
+5,312
New +$292K ﹤0.01% 1043

Other funds holding HRMY